• Chemerin in cNTS Drives Sympathetic Activity via Superoxide

  2026-07-02

  This study uncovers that chemerin in the caudal nucleus tractus solitarius (cNTS) elevates sympathetic nerve activity and blood pressure by activating a CMKLR1–NADPH oxidase–superoxide pathway. The findings clarify which glutamatergic receptor systems are involved and provide methodological guidance for dissecting neurocardiovascular mechanisms.

• EZH2 Regulates Endothelial Protection Against Oxidative Stre

  2026-07-02

  This study uncovers how salidroside (SAL) protects endothelial cells from hydrogen peroxide-induced dysfunction by modulating inflammation and autophagy through EZH2. The findings provide mechanistic insight into EZH2 as a therapeutic target in vascular disease and inform the use of selective EZH2 inhibitors in cardiovascular and broader epigenetics research.

• Lithium-Driven Exosomal Wnt10a and β-Catenin Boost Osteogene

  2026-07-01

  This study reveals that lithium enhances osteogenesis by promoting exosomal Wnt10a secretion from bone mesenchymal stem cells (BMSCs) via Rab11a-mediated trafficking, resulting in potent activation of β-catenin signaling. These insights clarify the cellular mechanisms by which lithium optimizes BMSC-based bone regeneration strategies, opening avenues for engineered exosome therapies in bone repair.

• D-Luciferin in Translational Oncology: Illuminating PD-L1 Dy

  2026-07-01

  This thought-leadership article explores the mechanistic role of D-Luciferin as a firefly luciferase substrate for quantitative bioluminescence imaging in translational oncology, with a focus on tracking soluble PD-L1 dynamics in glioma. Drawing on recent discoveries linking the Wnt/β-catenin pathway to immune evasion in glioma, the article provides actionable guidance for researchers seeking to deploy D-Luciferin-powered assays for biomarker validation, tumor burden assessment, and immunotherapy optimization. Workflow parameters, competitive context, and strategic foresight are addressed, bridging mechanistic insight with practical translational impact.

• Structural Genomics Reveals Remote Protein Homologs in Insec

  2026-06-30

  This study presents a large-scale structural genomics analysis across insects, providing new protein function annotations and uncovering remote homologs missed by sequence-based methods. The findings highlight how structure-based approaches bridge evolutionary gaps and inform functional genomics, with implications for comparative biology and immune research.

• Salvianolic Acid B Targets LH2 to Attenuate Pulmonary Fibros

  2026-06-30

  The reference study identifies Salvianolic acid B (Dan Shen Suan B) as a potent inhibitor of lysyl hydroxylase 2 (LH2), demonstrating its ability to disrupt pathological collagen cross-linking and extracellular matrix stiffening in pulmonary fibrosis models. These findings offer a targeted, mechanistically validated strategy for antifibrotic intervention and highlight new directions for research on extracellular matrix remodeling.

• Optimizing Cy5 RNA Probe Synthesis for Translational Discove

  2026-06-29

  This thought-leadership article unpacks the mechanistic, methodological, and translational value of the HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit. By linking advanced probe synthesis to breakthroughs in efferocytosis and mRNA delivery, it provides strategic guidance for translational researchers navigating the intersection of cellular mechanism, experimental rigor, and next-generation therapeutics. Evidence from recent literature and real-world workflows informs best practices and sets new standards for sensitivity and reproducibility.

• Preclinical Characterization of Anlotinib: Selective VEGFR2

  2026-06-29

  This article reviews the pivotal preclinical study that established anlotinib hydrochloride as a highly potent and selective multi-target tyrosine kinase inhibitor, focusing on its blockade of VEGFR2-mediated angiogenesis. The findings highlight anlotinib’s exceptional efficacy in anti-angiogenic assays and its translational value for cancer research.

• Tamsulosin for Ureteral Stone Expulsion: Meta-Analysis Insig

  2026-06-28

  A comprehensive meta-analysis clarifies the efficacy of Tamsulosin—(R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide—for symptomatic ureteral stone expulsion, overcoming controversy from recent mixed clinical trial results. The findings support Tamsulosin's use in increasing stone clearance rates and reducing expulsion time, with a favorable safety profile, informing future translational and clinical urological research.

• DPP-4 Inhibition Reimagined: Translational Leverage of Sitag

  2026-06-27

  This thought-leadership article explores how sitagliptin phosphate monohydrate, a potent DPP-4 inhibitor from APExBIO, is reshaping translational type II diabetes research. Integrating recent insights into gastrointestinal mechanotransduction and incretin hormone biology, the article provides researchers with mechanistic clarity, evidence-based protocol guidance, and strategic perspectives for advancing metabolic disease models beyond glycemic endpoints.

• N3-kethoxal: Precision Genomic Mapping with Click Chemistry

  2026-06-26

  N3-kethoxal empowers researchers to pinpoint accessible, single-stranded DNA and RNA regions with high specificity, leveraging its unique azide functionality for click chemistry-based labeling. Its integration into advanced workflows like KAS-ATAC sequencing reveals regulatory landscapes at single-molecule resolution, bridging in vitro and in vivo discovery.

• Preclinical Insights: Anlotinib Hydrochloride as a Selective

  2026-06-26

  The reference study rigorously characterizes anlotinib hydrochloride as a highly selective and potent VEGFR2 inhibitor with significant anti-angiogenic efficacy in preclinical models. These findings establish a mechanistic and comparative foundation for advancing multi-target tyrosine kinase inhibition in cancer research and translational anti-angiogenic studies.

• AMG 9810: Optimizing TRPV1 Antagonist Workflows in Pain Rese

  2026-06-25

  AMG 9810 stands out as a nanomolar TRPV1 antagonist, enabling robust inhibition of capsaicin-induced signaling in sensory neuron assays. This article details protocol parameters, advanced applications, and troubleshooting strategies to maximize reproducibility in pain mechanism research.

• Ivermectin as a Broad-Spectrum Anti-Parasitic: Applied Proto

  2026-06-25

  Harness Ivermectin’s high-purity and robust anti-parasitic action to streamline experimental workflows in parasitology research and drug development. This guide details practical setup, protocol enhancements, and troubleshooting strategies, integrating insights from cutting-edge tumor biology to inspire next-generation assay design.

• Bifendate Disrupts Autophagy and Reduces Fatty Acid-Induced

  2026-06-24

  This study reveals that bifendate (DDB), a clinically relevant hepatoprotective agent, inhibits autophagy at multiple steps, including autophagosome-lysosome fusion and lysosomal acidification. Importantly, DDB also reduces oleic acid-induced intracellular lipid droplet accumulation, providing mechanistic insight into its protective effects in hepatic steatosis.

15545 records 1/1037 page Next 12345 下5页 Last page